Reductions in bone mass in individuals with type 1 diabetes has been shown to result from the diminished secretion and/or action of insulin, which is associated with the formation of advanced glycation end-products (AGEs), induced by oxidative stress and hyperglycemia. This evidence concerns the gene INS and Hyperglycemia.